Hepatitis B immune globulin (OMRIX Biopharmaceuticals)
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHepatitis B immune globulin (OMRIX Biopharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2006/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOmrix Biopharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesOmrix Biopharmaceuticals
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A